Senior operating executive across the healthcare ecosystem. As former Vice President, Medical Innovations for Danaher s diagnostics platform DH Diagnostics, LLC, Dr. Egbuonu-Davis provided medical advice to influence research, partnerships and investment strategy across Danaher s diagnostic platform businesses. She also served as Interim Chief Medical Officer to Leica and Beckman Coulter, Danaher subsidiaries, providing executive-level medical and operational oversight over new processes for R&D and product innovation. Earlier, Dr. Egbuonu-Davis spent 13 years at Pfizer in leadership roles, including Vice President of U.S. Medical Operations, where she led clinical and outcomes research, supported reimbursement strategy and value assessment, and influenced product development and investment decisions across Pfizer s portfolio. Deep experience driving patient-centered outcomes and engagement at scale. Her career spans pharmaceuticals, diagnostics and MedTech innovation as well as advisory roles with Avalere Health and Booz Allen Hamilton. Her wide-ranging health and medical experience provide her with a comprehensive understanding of how providers, payers and life sciences organizations evaluate health care quality, clinical value and technology adoption. Drawing on behavioral science and patient-reported data, she built frameworks that translated real-world clinical evidence into economic value for payers and providers, connecting patient engagement strategy directly to reimbursement and market access outcomes. At Sanofi, Dr. Egbuonu-Davis developed and led adherence programs and patient services designed to improve measurable outcomes in chronic disease populations. Board and compliance oversight expertise. Dr. Egbuonu-Davis serves on the boards of Omega Healthcare Investors, a real estate investment trust focused on long-term healthcare facilities, and Avanos Medical, a medical device company with products for orthopedic pain and digestive health, where her committee service spans compensation, nominating and governance, and compliance. Her experience with regulatory and compliance matters at public companies in both the healthcare services and MedTech sectors equips her to oversee a public healthcare company subject to laws, regulations and industry standards. Dr. Egbuonu-Davis holds a Master of Business Administration in Health Care Management from The Wharton School of the University of Pennsylvania, and she holds Doctor of Medicine and Master of Public Health (epidemiology) degrees from Johns Hopkins University. She is board certified in pediatrics. Dr. Lisa Egbuonu-Davis combination of clinical training, public health expertise and senior operating leadership across global healthcare organizations uniquely positions her to support Phreesia s patient engagement strategy, data-driven innovation and commitment to improving outcomes across the care continuum. We believe Dr. Egbuonu-Davis's strategic and operational experience in pharmaceuticals, public health and consulting, including expertise in developing and implementing research, commercialization and investment strategies for a variety of patient populations, in addition to her medical and public health expertise, make her qualified to serve on our Board.